title: Management of human papillomavirus-related anal and colon cancer.
abstract: The incidence of human papillomavirus (HPV) and HPV-related anal cancer has been increasing at an alarming rate. Human immunodeficiency virus-positive patients are at a particularly high risk, with prevalence increasing rapidly in this population as life expectancies have increased. Screening has been very effective in reducing the morbidity and mortality of HPV-related cervical cancer, which suggests its role in reducing the burden of HPV-related anal cancer as well. With appropriate screening, patient education and treatment, the incidence of HPV-related anal cancer may be greatly reduced.
authors.affiliation: Arlington Center for Dermatology, Arlington Research Center, Arlington, Tex., USA.
authors.forename: Angela
authors.initials: A
authors.lastname: Yen Moore
authors.forename: Lana X
authors.initials: LX
authors.lastname: Tong
authors.forename: Todd
authors.initials: T
authors.lastname: Moore
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D006801:Humans; D008403:Mass Screening / Q000379:methods; D030361:Papillomavirus Infections / Q000150:complications* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D053918:Papillomavirus Vaccines